The identification of similar gene expression patterns in PBMCs, particularly in genes involved in pathways such as KRAS signaling, p53 pathway, TNFα signaling, and hypoxia response, underscores the utility of our approach for PBMC-based molecular diagnostics in PAH. The gene discussed is KRAS; the disease is pulmonary arterial hypertension.